Industry Research Reports and Market Analysis at MindBranch.com

Brazil Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Published By: Global Markets Direct
May 2009
R3480-13931
Online Download   $2,500.00
Global Site License   $7,500.00
Description

Brazil Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Brazil cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices market in Brazil

Scope
  • The report provides cardiovascular devices market information broken down into detailed categories and segments in Brazil.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the cardiovascular devices market in Brazil.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Table of Contents
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 Cardiovascular Devices
3.2 Cardiac Rhythm Management
3.2.1 Pacemakers
3.2.1.1 Single Chamber Pacemakers
3.2.1.2 Dual Chamber Pacemakers
3.2.2 Implantable Cardioverter Defibrillator (ICD)
3.2.2.1 Single Chamber Implantable Cardioverter Defibrillator
3.2.2.2 Dual Chamber Implantable Cardioverter Defibrillator
3.2.3 Cardiovascular Pacing and ICD Leads
3.2.4 Cardiac Resynchronization Therapy
3.2.4.1 Cardiac Resynchronisation Therapy - Pacemaker
3.2.4.2 Cardiac Resynchronisation Therapy - Defibrillator
3.3 Cardiovascular monitoring and diagnostic devices
3.3.1 ECG Monitoring Equipment
3.3.2 ECG Stress Testing Systems
3.3.3 Holter Monitoring Systems
3.3.4 Event Monitoring Systems
3.4 Cardiovascular prosthetic device
3.4.1 Prosthetic heart valves
3.4.1.1 Mechanical heart valves
3.4.1.2 Tissue heart valve
3.4.2 Cardiac Valve Repair
3.4.3 Cardiac assist devices (Ventricular Assist Device (VAD))
3.4.3.1 Total Artificial Heart (TAH)
3.4.3.2 Intra Aortic Balloon Pump (IABP)
3.4.3.3 Intra Aortic Balloon Pump Catheters
3.5 Cardiovascular Surgery
3.5.1 Beating Heart Systems
3.5.2 Perfusion Systems
3.5.3 Cardiac Ablation Devices
3.5.4 Cardiopulmonary Bypass Equipment
3.5.5 Perfusion Disposables
3.5.5.1 Oxygenators
3.5.5.2 Custom Packs
3.6 Electrophysiology
3.6.1 Electrophysiology diagnostic catheter
3.6.2 Electrophysiology ablation catheter
3.6.3 Electrophysiology lab systems
3.7 Interventional cardiology
3.7.1 Coronary Stents
3.7.1.1 Bare Metal Stents
3.7.1.2 Drug Eluting Coronary Stents
3.7.2 Cardiac Catheters
3.7.2.1 Guiding Catheters
3.7.2.2 Angiography catheters
3.7.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters
3.7.3.1 Rapid Exchange PTCA Balloon Catheters
3.7.3.2 Over the Wire PTCA Balloon Catheters
3.7.3.3 Fixed Wire (FW) PTCA Balloon Catheters
3.7.4 Coronary Guidewire
3.7.5 Arteriotomy Closure Devices
3.8 Peripheral vascular devices
3.8.1 Peripheral Vascular Stents
3.8.2 Inferior Vena Cava Filter
3.8.3 PTA Balloon
3.8.4 Aortic Stent Graft
3.8.5 Embolic Protection Device
3.8.6 Synthetic Surgical Grafts
3.8.7 Peripheral Guidewire
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.2.1 Healthcare Personnel Data
4.2.2 Healthcare Facilities Data
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval
5.2 Central Drugs Authority of India (CDAI)
5.3 Medical Device Regulatory Authority of India (MDRAI)
5.4 Classification of medical devices
5.4.1 Registration Period
6 Pricing and Reimbursement
6.1 Pricing and Reimbursement
7 Distribution Structure
7.1 Distribution Structure
8 Cardiovascular Devices in India
8.1 Cardiovascular Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015
8.2 Cardiovascular Devices, India, Overall Revenue ($ mn), 2000-2015
8.3 Cardiovascular Devices, India, Category Volume (Units), 2000-2015
8.4 Cardiovascular Devices, India, Company Share (2007-2008)
9 Cardiac Rhythm Management in India
9.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
9.1.1 Cardiac Resynchronisation Therapy Revenue (2000-2015)
9.1.2 Implantable Cardioverter Defibrillator Revenue (2000-2015)
9.1.3 Pacemaker Revenue (2000-2015)
9.2 Cardiac Rhythm Management Overall Volume (2000-2015)
9.2.1 Cardiac Resynchronisation Therapy Volume (2000-2015)
9.2.2 Implantable Cardioverter Defibrillator Volume (2000-2015)
9.2.3 Pacemaker Volume (2000-2015)
9.3 Cardiac Rhythm Management Average Price (2000-2015)
9.4 Cardiac Rhythm Management Distribution Share (2007-2008)
9.5 Cardiac Rhythm Management, India, Company Share (2007-2008)
10 Cardiovascular Monitoring and Diagnostic Devices in India
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015)
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008)
10.5 Cardiovascular Monitoring and Diagnostic Devices, India, Company Share (2007-2008)
11 Cardiovascular Prosthetic Devices in India
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015)
11.1.1 Cardiac Assist Devices Revenue (2000-2015)
11.1.2 Prosthetic Heart Valve Revenue (2000-2015)
11.1.3 Cardiac Valve Repair Revenue (2000-2015)
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015)
11.2.1 Cardiac Assist Devices Volume (2000-2015)
11.2.2 Prosthetic Heart Valve Volume (2000-2015)
11.2.3 Cardiac Valve Repair Overall Volume (2000-2015)
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
11.5 Cardiovascular Prosthetic Devices, India, Company Share (2007-2008)\
12 Cardiovascular Surgery in India
12.1 Cardiovascular Surgery Overall Revenue (2000-2015)
12.1.1 Perfusion Disposables Revenue (2000-2015)
12.2 Cardiovascular Surgery Overall Volume (2000-2015)
12.2.1 Perfusion Disposables Volume (2000-2015)
12.3 Cardiovascular Surgery Average Price (2000-2015)
12.4 Cardiovascular Surgery Distribution Share (2007-2008)
12.5 Cardiovascular Surgery, India, Company Share (2007-2008)
13 Electrophysiology in India
13.1 Electrophysiology Overall Revenue (2000-2015)
13.2 Electrophysiology Overall Volume (2000-2015)
13.3 Electrophysiology Average Price (2000-2015)
13.4 Electrophysiology Distribution Share (2007-2008)
13.5 Electrophysiology, India, Company Share (2007-2008)
14 Interventional Cardiology in India
14.1 Interventional Cardiology Overall Revenue (2000-2015)
14.1.1 Cardiac Catheter Revenue (2000-2015)
14.1.2 Coronary Stent Revenue (2000-2015)
14.1.3 PTCA Balloon Revenue (2000-2015)
14.2 Interventional Cardiology Overall Volume (2000-2015)
14.2.1 Cardiac Catheter Volume (2000-2015)
14.2.2 Coronary Stent Volume (2000-2015)
14.2.3 PTCA Balloon Volume (2000-2015)
14.3 Interventional Cardiology Average Price (2000-2015)
14.4 Interventional Cardiology Distribution Share (2007-2008)
14.5 Interventional Cardiology, India, Company Share (2007-2008)
15 Peripheral Vascular Devices in India
15.1 Peripheral Vascular Devices Overall Revenue (2000-2015)
15.2 Peripheral Vascular Devices Overall Volume (2000-2015)
15.3 Peripheral Vascular Devices Average Price (2000-2015)
15.4 Peripheral Vascular Devices Distribution Share (2007-2008)
15.5 Peripheral Vascular Devices, India, Company Share (2007-2008)
16 Overview of Key Companies in India Cardiovascular Devices Market
16.1 Boston Scientific Corporation
16.1.1 Company Overview
16.1.2 Value Chain Analysis
16.1.2.1 Manufacturing
16.1.2.2 Product Development
16.1.2.3 Sales and Marketing
16.1.3 Boston Scientific Corporation Pipeline Products
16.1.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type
16.1.3.2 Boston Scientific Corporation Pipeline Products by Development Stage
16.1.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area
16.1.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials
16.1.3.5 Boston Scientific Corporation Pipeline Products by News Summary
16.2 Medtronic, Inc.
16.2.1 Company Overview
16.2.2 Value Chain Analysis
16.2.2.1 Manufacturing
16.2.2.2 Product Development
16.2.2.3 Sales and Marketing
16.2.3 Medtronic, Inc. Pipeline Products
16.2.3.1 Medtronic, Inc. Pipeline Products by Equipment Type
16.2.3.2 Medtronic, Inc. Pipeline Products by Development Stage
16.2.3.3 Medtronic, Inc. Pipeline Products by Therapy Area
16.2.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials
16.2.3.5 Medtronic, Inc. Pipeline Products by News Summary
16.3 Cordis Corporation
16.3.1 Company Overview
16.3.2 Cordis Corporation Pipeline Products
16.3.2.1 Cordis Corporation Pipeline Products by Equipment Type
16.3.2.2 Cordis Corporation Pipeline Products by Development Stage
16.3.2.3 Cordis Corporation Pipeline Products by Therapy Area
16.3.2.4 Cordis Corporation Pipeline Products by Clinical Trials
16.3.2.5 Cordis Corporation Pipeline Products by News Summary
16.4 Abbott Laboratories
16.4.1 Company Overview
16.4.2 Value Chain Analysis
16.4.2.1 Manufacturing
16.4.2.2 Product Development
16.4.2.3 Sales and Marketing
16.5 St. Jude Medical Inc.
16.5.1 Company Overview
16.5.2 Value Chain Analysis
16.5.2.1 Manufacturing
16.5.2.2 Product Development
16.5.2.3 Sales and Marketing
16.5.3 St. Jude Medical Inc. Pipeline Products
16.5.3.1 St. Jude Medical Inc. Pipeline Products by Equipment Type
16.5.3.2 St. Jude Medical Inc. Pipeline Products by Development Stage
16.5.3.3 St. Jude Medical Inc. Pipeline Products by Therapy Area
16.5.3.4 St. Jude Medical Inc. Pipeline Products by Clinical Trials
16.5.3.5 St. Jude Medical Inc. Pipeline Products by News Summary
16.6 BIOTRONIK GmbH & Co. KG
16.6.1 Company Overview
16.6.2 BIOTRONIK GmbH & Co. KG Pipeline Products
16.6.2.1 BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type
16.6.2.2 BIOTRONIK GmbH & Co. KG Pipeline Products by Development Stage
16.6.2.3 BIOTRONIK GmbH & Co. KG Pipeline Products by Therapy Area
16.6.2.4 BIOTRONIK GmbH & Co. KG Pipeline Products by Clinical Trials
16.6.2.5 BIOTRONIK GmbH & Co. KG Pipeline Products by News Summary
16.7 Shree Pacetronix Ltd.
16.7.1 Company Overview
16.8 Terumo Corporation
16.8.1 Company Overview
16.8.2 Value Chain Analysis
16.8.2.1 Manufacturing
16.8.2.2 Product Development
16.8.2.3 Sales and Marketing
16.8.3 Terumo Corporation Pipeline Products
16.8.3.1 Terumo Corporation Pipeline Products by Equipment Type
16.8.3.2 Terumo Corporation Pipeline Products by Development Stage
16.8.3.3 Terumo Corporation Pipeline Products by Therapy Area
16.8.3.4 Terumo Corporation Pipeline Products by Clinical Trials
16.8.3.5 Terumo Corporation Pipeline Products by News Summary
16.9 Sorin S.p.A.
16.9.1 Company Overview
16.9.2 Value Chain Analysis
16.9.2.1 Manufacturing
16.9.2.2 Product Development
16.9.2.3 Sales and Marketing
16.9.3 Sorin Group Pipeline Products
16.9.3.1 Sorin Group Pipeline Products by Equipment Type
16.9.3.2 Sorin Group Pipeline Products by Development Stage
16.9.3.3 Sorin Group Pipeline Products by Therapy Area
16.9.3.4 Sorin Group Pipeline Products by Clinical Trials
16.9.3.5 Sorin Group Pipeline Products by News Summary
16.10 GE Healthcare
16.10.1 Company Overview
16.11 Philips Healthcare
16.11.1 Company Overview
16.11.2 Value Chain Analysis
16.11.2.1 Manufacturing
16.11.2.2 Product Development
16.11.2.3 Sales and Marketing
16.11.3 Philips Medical Systems Pipeline Products
16.11.3.1 Philips Medical Systems Pipeline Products by Equipment Type
16.11.3.2 Philips Medical Systems Pipeline Products by Development Stage
16.11.3.3 Philips Medical Systems Pipeline Products by Therapy Area
16.11.3.4 Philips Medical Systems Pipeline Products by Clinical Trials
16.11.3.5 Philips Medical Systems Pipeline Products by News Summary
16.12 OSI Systems, Inc.
16.12.1 Company Overview
16.12.2 Value Chain Analysis
16.12.2.1 Manufacturing
16.12.2.2 Product Development
16.12.2.3 Sales and Marketing
16.13 Cardiac Science Corporation
16.13.1 Company Overview
16.13.2 Value Chain Analysis
16.13.2.1 Manufacturing
16.13.2.2 Product Development
16.13.2.3 Sales and Marketing
16.14 Nihon Kohden Corporation
16.14.1 Company Overview
16.14.2 Value Chain Analysis
16.14.2.1 Manufacturing
16.14.2.2 Product Development
16.14.2.3 Sales and Marketing
16.15 Welch Allyn Inc.
16.15.1 Company Overview
16.16 Edwards Lifesciences Corporation
16.16.1 Company Overview
16.16.2 Value Chain Analysis
16.16.2.1 Manufacturing
16.16.2.2 Product Development
16.16.2.3 Sales and Marketing
16.16.3 Edwards Lifesciences Corporation Pipeline Products
16.16.3.1 Edwards Lifesciences Corporation Pipeline Products by Equipment Type
16.16.3.2 Edwards Lifesciences Corporation Pipeline Products by Development Stage
16.16.3.3 Edwards Lifesciences Corporation Pipeline Products by Therapy Area
16.16.3.4 Edwards Lifesciences Corporation Pipeline Products by Clinical Trials
16.16.3.5 Edwards Lifesciences Corporation Pipeline Products by News Summary
16.17 Arrow International, Inc.
16.17.1 Company Overview
16.17.2 Value Chain Analysis
16.17.2.1 Manufacturing
16.17.2.2 Product Development
16.17.2.3 Sales and Marketing
16.17.3 Arrow International, Inc. Pipeline Products
16.17.3.1 Arrow International, Inc. Pipeline Products by Equipment Type
16.17.3.2 Arrow International, Inc. Pipeline Products by Development Stage
16.17.3.3 Arrow International, Inc. Pipeline Products by Therapy Area
16.17.3.4 Arrow International, Inc. Pipeline Products by Clinical Trials
16.18 ABIOMED, Inc.
16.18.1 Company Overview
16.18.2 Value Chain Analysis
16.18.2.1 Manufacturing
16.18.2.2 Product Development
16.18.2.3 Sales and Marketing
16.18.3 ABIOMED, Inc. Pipeline Products
16.18.3.1 ABIOMED, Inc. Pipeline Products by Equipment Type
16.18.3.2 ABIOMED, Inc. Pipeline Products by Development Stage
16.18.3.3 ABIOMED, Inc. Pipeline Products by Therapy Area
16.18.3.4 ABIOMED, Inc. Pipeline Products by Clinical Trials
16.18.3.5 ABIOMED, Inc. Pipeline Products by News Summary
16.19 MAQUET GmbH & Co. KG
16.19.1 Company Overview
16.20 AtriCure, Inc.
16.20.1 Company Overview
16.20.2 AtriCure, Inc. Pipeline Products
16.20.2.1 AtriCure, Inc. Pipeline Products by Equipment Type
16.20.2.2 AtriCure, Inc. Pipeline Products by Development Stage
16.20.2.3 AtriCure, Inc. Pipeline Products by Therapy Area
16.20.2.4 AtriCure, Inc. Pipeline Products by Clinical Trials
16.20.2.5 AtriCure, Inc. Pipeline Products by News Summary
16.21 Biosense Webster, Inc.
16.21.1 Company Overview
16.22 C.R. Bard, Inc.
16.22.1 Company Overview
16.22.2 Value Chain Analysis
16.22.2.1 Manufacturing
16.22.2.2 Product Development
16.22.2.3 Sales and Marketing
16.22.3 C.R. Bard, Inc. Pipeline Products
16.22.3.1 C.R. Bard, Inc. Pipeline Products by Equipment Type
16.22.3.2 C.R. Bard, Inc. Pipeline Products by Development Stage
16.22.3.3 C.R. Bard, Inc. Pipeline Products by Therapy Area
16.22.3.4 C.R. Bard, Inc. Pipeline Products by Clinical Trials
16.23 ev3 Inc.
16.23.1 Company Overview
16.23.2 Value Chain Analysis
16.23.2.1 Manufacturing
16.23.2.2 Product Development
16.23.2.3 Sales and Marketing
16.23.3 ev3 Inc. Pipeline Products
16.23.3.1 ev3 Inc. Pipeline Products by Equipment Type
16.23.3.2 ev3 Inc. Pipeline Products by Development Stage
16.23.3.3 ev3 Inc. Pipeline Products by Therapy Area
16.23.3.4 ev3 Inc. Pipeline Products by Clinical Trials
16.23.3.5 ev3 Inc. Pipeline Products by News Summary
16.24 Sahajanand Medical technologies Pvt. Ltd.
16.24.1 Company Overview
16.24.2 Sahajanand Medical technologies Pvt. Ltd. Pipeline Products
16.24.2.1 Sahajanand Medical technologies Pvt. Ltd. Pipeline Products by Equipment Type
16.24.2.2 Sahajanand Medical technologies Pvt. Ltd. Pipeline Products by Development Stage
16.24.2.3 Sahajanand Medical technologies Pvt. Ltd. Pipeline Products by Therapy Area
16.24.2.4 Sahajanand Medical technologies Pvt. Ltd. Pipeline Products by Clinical Trials
16.24.2.5 Sahajanand Medical technologies Pvt. Ltd. Pipeline Products by News Summary
16.25 Vascular Concepts Limited
16.25.1 Company Overview
16.25.2 Vascular Concepts Limited Pipeline Products
16.25.2.1 Vascular Concepts Limited Pipeline Products by Equipment Type
16.25.2.2 Vascular Concepts Limited Pipeline Products by Development Stage
16.25.2.3 Vascular Concepts Limited Pipeline Products by Therapy Area
16.25.2.4 Vascular Concepts Limited Pipeline Products by Clinical Trials
16.26 HEXACATH
16.26.1 Company Overview
16.27 Fukuda Denshi Co., Ltd.
16.27.1 Company Overview
16.28 Schiller Healthcare India Pvt. Ltd.
16.28.1 Company Overview
16.29 B. L. Lifesciences Private Limited
16.29.1 Company Overview
16.30 CR Medisystems Pvt. Ltd.
16.30.1 Company Overview
16.31 BPL Healthcare Business Group
16.31.1 Company Overview
17 Financial Deals Landscape
17.1 Partnerships
17.1.1 Welch Allyn Enters Into An Agreement With BPL Healthcare
18 Recent Developments
18.1 Strategy And Business Planning
18.1.1 Apr 26, 2009: Covidien Enters Into Indian Market, Establishes Headquarters At Gurgaon, India
19 Appendix
19.1 Global Markets Direct Research Methodology
19.2 Coverage
19.3 Secondary Research
19.4 Primary Research
19.5 Models
19.6 Forecasts
19.7 Expert Panel Validation
19.8 Currency Conversion
19.9 Contact Us
19.10 Disclaimer
1.1 List of Tables
Table 1: Medical Device Registration Fee in Brazil, 2002
Table 2: Cardiovascular Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
Table 3: Cardiovascular Devices, Brazil, Overall Revenue ($ mn), 2000-2015
Table 4: Cardiovascular Devices, Brazil, Cross-Category Analysis, 2000-2015
Table 5: Cardiovascular Devices, Brazil, Overall Revenue ($ mn), Historic, 2000-2008
Table 6: Cardiovascular Devices, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015
Table 7: Cardiovascular Devices, Brazil, Category Volume (Units), 2000-2015
Table 8: Cardiovascular Devices, Brazil, Category Volume (Units), Historic, 2000-2008
Table 9: Cardiovascular Devices, Brazil, Category Volume (Units), Forecast, 2008-2015
Table 10: Cardiovascular Devices, Brazil, Company Share by Revenue ($ mn), 2007-2008
Table 11: Cardiac Rhythm Management, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 12: Cardiac Rhythm Management, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 13: Cardiac Resynchronisation Therapy, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 14: Cardiac Resynchronisation Therapy, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 15: Implantable Cardioverter Defibrillator, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 16: Implantable Cardioverter Defibrillator, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 17: Pacemaker, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 18: Pacemaker, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 19: Cardiac Rhythm Management, Brazil, Volume (Units) by Segment, Historic, 2000-2008
Table 20: Cardiac Rhythm Management, Brazil, Volume (Units) by Segment, Forecast, 2008-2015
Table 21: Cardiac Resynchronisation Therapy, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 22: Cardiac Resynchronisation Therapy, Brazil, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 23: Implantable Cardioverter Defibrillator, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 24: Implantable Cardioverter Defibrillator, Brazil, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 25: Pacemaker, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 26: Pacemaker, Brazil, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 27: Cardiac Rhythm Management, Brazil, Average Price ($), Historic, 2000-2008
Table 28: Cardiac Rhythm Management, Brazil, Average Price ($), Forecast, 2008-2015
Table 29: Cardiac Rhythm Management, Brazil, Distribution Share by Revenue ($mn), 2007-2008
Table 30: Cardiac Rhythm Management, Brazil, Company Share by Revenue ($ mn), 2007-2008
Table 31: Cardiovascular Monitoring and Diagnostic Devices, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 32: Cardiovascular Monitoring and Diagnostic Devices, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 33: Cardiovascular Monitoring and Diagnostic Devices, Brazil, Volume (Units) by Segment, Historic, 2000-2008
Table 34: Cardiovascular Monitoring and Diagnostic Devices, Brazil, Volume (Units) by Segment, Forecast, 2008-2015
Table 35: Cardiovascular Monitoring and Diagnostic Devices, Brazil, Average Price ($), Historic, 2000-2008
Table 36: Cardiovascular Monitoring and Diagnostic Devices, Brazil, Average Price ($), Forecast, 2008-2015
Table 37: Cardiovascular Monitoring and Diagnostic Devices, Brazil, Distribution Share by Revenue ($mn), 2007-2008
Table 38: Cardiovascular Monitoring and Diagnostic Devices, Brazil, Company Share by Revenue ($ mn), 2007-2008
Table 39: Cardiovascular Prosthetic Devices, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 40: Cardiovascular Prosthetic Devices, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 41: Cardiac Assist Devices, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 42: Cardiac Assist Devices, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 43: Prosthetic Heart Valve, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 44: Prosthetic Heart Valve, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 45: Cardiovascular Prosthetic Devices, Brazil, Volume (Units) by Segment, Historic, 2000-2008
Table 46: Cardiovascular Prosthetic Devices, Brazil, Volume (Units) by Segment, Forecast, 2008-2015
Table 47: Cardiac Assist Devices, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 48: Cardiac Assist Devices, Brazil, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 49: Prosthetic Heart Valve, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2008
Table 50: Prosthetic Heart Valve, Brazil, Volume (Units) by Sub-Segment, Forecast, 2008-2015
Table 51: Cardiovascular Prosthetic Devices, Brazil, Average Price ($), Historic, 2000-2008
Table 52: Cardiovascular Prosthetic Devices, Brazil, Average Price ($), Forecast, 2008-2015
Table 53: Cardiovascular Prosthetic Devices, Brazil, Distribution Share by Revenue ($mn), 2007-2008
Table 54: Cardiovascular Prosthetic Devices, Brazil, Company Share by Revenue ($ mn), 2007-2008
Table 55: Cardiovascular Surgery, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 56: Cardiovascular Surgery, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 57: Perfusion Disposables, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
Table 58: Perfusion Disposables, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
Table 59: Cardiovascular Surgery, Brazil, Volume (Units) by Segment, Historic, 2000-2008
Table 60: Cardiovascular Surgery, Brazil, Volume (Units) by Segment, Forecast, 2
Order Form
       * Please reference product number R3480-13931 when ordering or inquiring.
PUBLICATION:   Brazil Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
QTY. FORMAT PRICE TOTAL
  Online Download$2,500.00   
  Global Site License$7,500.00   
  SUBTOTAL   
SHIPPING CHARGES
 (U.S. $25, Canada $35, Int'l $65) 		 
TOTAL  

CONTACT INFORMATION
PAYMENT INFORMATION
Name ____________________________________________ MasterCard VISA AmEx Discover

__________________________________
Account number                 Exp. date

__________________________________
Signature

__________________________________
Email

Please invoice
      (shipment on receipt of payment)
Payment enclosed
*CHECKS / WIRE TRANSFERS:
Checks must be paid in U.S. funds.
Please call for details.
Company ____________________________________________
Job Title ____________________________________________
Address ____________________________________________
City ____________________________________________
Company ____________________________________________
State ______________________________   Zip__________
Country ____________________________________________
Phone ____________________________________________
MindBranch, Inc.,     131 Ashland St., Suite 200 North Adams, MA  01247       tel: 800-774-4410     fax: +1-413-664-9791     www.mindbranch.com